LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Accounts Payable, Related Parties
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Accounts Payable, Related Parties of $110.00 thousand for the 12-month period ending 2015-05-31, per its 10-K filed 2015-07-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2015-07-31
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2015-05-31 was $98.00K, a 83.28% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2015-03-01 was -$186.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2014-11-30 was $165.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2014-08-31 was $33.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for fiscal 2015 was $110.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for fiscal 2014 was -$91.00K, a 1010.00% decline from fiscal 2013.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for fiscal 2013 was $10.00K, a 97.90% decline from fiscal 2012.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in accounts payable, related parties for fiscal 2012 was $476.00K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2015-05-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | -$88.00K derived: sum of 2 quarters · filed 2015-07-31 | $77.00K derived: sum of 3 quarters · filed 2015-07-31 | $110.00K 10-K · filed 2015-07-31 |
| 2015-03-01 | -$186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$21.00K derived: sum of 2 quarters · filed 2015-04-02 | $12.00K 10-Q · filed 2015-04-02 | $598.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-11-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $198.00K 10-Q · filed 2015-01-09 | $784.00K derived: sum of 3 quarters · filed 2015-07-31 | $651.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-08-31 | $33.00K 10-Q · filed 2014-10-08 | $619.00K derived: sum of 2 quarters · filed 2015-07-31 | $486.00K derived: sum of 3 quarters · filed 2015-07-31 | $431.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2014-05-25 | $586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $453.00K derived: sum of 2 quarters · filed 2015-07-31 | $398.00K derived: sum of 3 quarters · filed 2015-07-31 | -$91.00K 10-K · filed 2015-07-31 |
| 2014-02-23 | -$133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$188.00K derived: sum of 2 quarters · filed 2015-04-02 | -$677.00K 10-Q · filed 2015-04-02 | -$82.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-11-24 | -$55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$544.00K 10-Q · filed 2015-01-09 | $51.00K derived: sum of 3 quarters · filed 2015-07-31 | -$183.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-08-25 | -$489.00K 10-Q · filed 2014-10-08 | $106.00K derived: sum of 2 quarters · filed 2015-07-31 | -$128.00K derived: sum of 3 quarters · filed 2015-07-31 | -$236.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-05-26 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $361.00K derived: sum of 2 quarters · filed 2015-07-31 | $253.00K derived: sum of 3 quarters · filed 2015-07-31 | $10.00K 10-K · filed 2015-07-31 |
| 2013-02-24 | -$234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$342.00K derived: sum of 2 quarters · filed 2014-03-28 | -$585.00K 10-Q · filed 2014-03-28 | -$26.00K derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-11-25 | -$108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$351.00K 10-Q · filed 2014-01-03 | $208.00K derived: sum of 3 quarters · filed 2014-08-01 | $93.00K derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-08-26 | -$243.00K 10-Q · filed 2013-09-26 | $316.00K derived: sum of 2 quarters · filed 2014-08-01 | $201.00K derived: sum of 3 quarters · filed 2014-08-01 | $162.00K derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-05-27 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $444.00K derived: sum of 2 quarters · filed 2014-08-01 | $405.00K derived: sum of 3 quarters · filed 2014-08-01 | $476.00K 10-K · filed 2014-08-01 |
| 2012-02-26 | -$115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | -$154.00K derived: sum of 2 quarters · filed 2013-04-04 | -$83.00K 10-Q · filed 2013-04-04 | $157.00K derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-11-27 | -$39.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $32.00K 10-Q · filed 2013-01-04 | $272.00K derived: sum of 3 quarters · filed 2013-08-07 | |
| 2011-08-28 | $71.00K 10-Q/A · filed 2013-01-02 | $311.00K derived: sum of 2 quarters · filed 2013-08-07 | ||
| 2011-05-29 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$49.00K 10-K · filed 2013-08-07 | ||
| 2011-02-27 | -$289.00K 10-Q · filed 2012-03-28 | |||
| 2010-11-28 | -$227.00K 10-Q · filed 2012-01-05 | |||
| 2010-08-29 | $162.00K 10-Q · filed 2011-10-05 | |||
| 2010-05-30 | $50.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |